Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China · Delayed Price · Currency is CNY 18.68
-0.23 (-1.22%)
Mar 20, 2026, 3:00 PM CST
SHA:600079 Market Cap
SHA:600079 has a market cap or net worth of 30.49 billion as of March 20, 2026. Its market cap has decreased by -7.32% in one year.
Market Cap
30.49B
Enterprise Value
37.69B
Revenue
24.18B
Ranking
n/a
PE Ratio
21.37
Stock Price
18.68
Market Cap Chart
Since January 2, 2001, SHA:600079's market cap has increased from 2.30B to 30.49B, an increase of 1,228.06%. That is a compound annual growth rate of 10.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 30.87B | 4.42% |
| Dec 31, 2025 | 29.56B | -21.41% |
| Dec 31, 2024 | 37.61B | -5.96% |
| Dec 29, 2023 | 40.00B | 4.04% |
| Dec 30, 2022 | 38.44B | 6.06% |
| Dec 31, 2021 | 36.25B | -30.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Tongrentang | 41.23B |
| Changchun High-Tech Industry (Group) | 36.37B |
| Dong-E-E-Jiao | 34.08B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 29.32B |
| Shijiazhuang Yiling Pharmaceutical | 28.30B |
| Livzon Pharmaceutical Group | 28.04B |
| Kangmei Pharmaceutical | 25.86B |
| Hubei Jumpcan Pharmaceutical | 25.32B |